ANVS

Annovis Bio Inc · NYSE

Sector Health Technology
Industry Pharmaceuticals: Major
Website annovisbio.com
Employees(FY) 5
ISIN US03615A1088

Performance

-12.29%

1W

-14.6%

1M

-35.64%

3M

-42.08%

6M

-68.72%

YTD

-59.99%

1Y

Profile

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Advanced Technical Analysis

Technical Analysis of ANVS 2024-05-31

Overview:

In analyzing the technical indicators for ANVS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key factors, we aim to offer valuable insights and predictions for informed decisio...

See more ...

Recent News & Updates

2024-06-10 20:00
Annovis Bio's Buntanetap Found Safe and Effective in High-Risk Alzheimer's Patients(Globenewswire)
2024-06-04 20:00
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast(Globenewswire)
2024-05-27 21:55
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 359.53%: Read This Before Placing a Bet(Zacks)
2024-05-20 19:30
Annovis Announces New Publication in a Peer-Reviewed Journal(Globenewswire)
2024-05-13 01:53
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024(Investorplace)
2024-05-12 19:30
Annovis Bio Provides Corporate Updates and Announces First Quarter 2024 Financial Results(Globenewswire)
2024-05-08 19:30
Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson's Disease(Globenewswire)
2024-05-05 19:30
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders(Globenewswire)
2024-04-29 22:17
Canaccord Genuity Cuts Price Target on Annovis Bio to $26 From $36, Maintains Buy Rating(Yahoo Finance)
2024-04-29 02:54
Top Midday Decliners(Yahoo Finance)
2024-04-29 00:12
Annovis Bio Shares Tumble After Drug Candidate Buntanetap for Alzheimer's Misses Efficacy Endpoint in Phase 2/3 Study(Yahoo Finance)
2024-04-28 22:51
UPDATE 3-Annovis tumbles as Alzheimer's treatment misses in mid-stage study(Yahoo Finance)
2024-04-28 22:20
CORRECTED- Annovis Bio fails to meet main goal of mid-stage Alzheimer's treatment trial(Yahoo Finance)
2024-04-28 22:10
Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer's Disease(Globenewswire)
2024-04-23 21:55
Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade(Zacks)
2024-04-07 21:55
Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?(Zacks)
2024-04-02 00:53
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023(Investorplace)
2024-04-01 19:30
Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results(Globenewswire)
2024-03-31 20:00
Annovis Announces Publication That Supports Understanding of Buntanetap's Mechanism of Action in Humans(Globenewswire)
2024-03-20 21:55
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet(Zacks)
2024-03-19 19:30
Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer's Disease(Globenewswire)
2024-03-17 20:52
Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock?(Zacks)
2024-03-06 02:33
Sell Signal: 3 Stocks to Unload Before the Bubble Bursts(Yahoo Finance)
2024-02-26 19:00
Annovis Bio Announces Participation in Forum Discussion at AD/PD 2024(Globenewswire)
2024-02-26 00:14
12 $10 Stocks That Will Triple(Yahoo Finance)
2024-02-13 18:30
Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer's Disease(Globenewswire)
2024-02-12 03:06
3 Growth Stocks to Sell in February Before They Bottom(Yahoo Finance)
2024-01-29 19:00
Annovis Bio Announces the Filing of New Patent Application for Treatment of Mental Illnesses Expanding the Company's Portfolio(Globenewswire)
2024-01-23 19:00
Annovis Bio Refines Timeline for Parkinson's Phase III Study Data Announcement(Globenewswire)
2023-12-21 03:13
These Stocks under $10 Are Poised To Explode(Yahoo Finance)

Page 1 of 5

previousnext